EN
HI
Summary
As of 2 Oct, 2026, Marksans Pharma stock price is ₹325.6. During the trading session, the stock has moved between an intraday low of ₹318.15 and an intraday high of ₹332.50. Over the last 52 weeks, Marksans Pharma has traded between ₹155.00 and ₹350.95.
The stock has recorded a trading volume of 24,45,782 shares,. Its Average Traded Price (ATP) is ₹325.11, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹325.60.
Marksans Pharma has an upper circuit limit of ₹386.75 and a lower circuit limit of ₹257.85. The total value traded stands at ₹79.51 CR, and the delivery percentage for the day is 48.45%.
The stock is currently traded with a market lot size of 1. Marksans Pharma also offers a dividend yield of 0.28%.
Marksans Pharma Share Price Chart
Marksans Pharma Share Key Metrics
Volume
24.46 L
Market Cap
14759.07 CR
LTQ@LTP
3@325.60
ATP
325.11
Var Margin
22.46 %
Circuit Range
257.85-386.75
Delivery %
48.45 %
Value
79.51 CR
ASM/GSM
No
Market Lot
1
Marksans Pharma Fundamentals
P/E Ratio
28.26
P/B Ratio
4.59
Div. Yield
0.28
Sector P/E
43.03
Sector P/B
3.62
Sec. Div. Yield
0.51
Marksans Pharma Resistance and Support
Pivot 329.73
Resistance
First Resistance
338.46
Second Resistance
354.63
Third Resistance
363.36
Support
First Support
313.56
Second Support
304.83
Third Support
288.66
Marksans Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 322.05 | 325.6 | 1.03% | 332.5 | 318.15 |
| Wed Sep 30 2026 | 344 | 322.29 | -5.97% | 345.89 | 321 |
| Tue Sep 29 2026 | 333 | 342.75 | 3.38% | 347.39 | 332.95 |
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Alembic Pharmaceuticals Ltd.
815.25
-10.20 (1.24%)
Eris Lifesciences Ltd.
1189.80
-2.10 (0.18%)
Jubilant Pharmova Ltd.
999.30
-29.50 (2.87%)
Poly Medicure Ltd.
1638.10
-35.70 (2.13%)
Dr. Agarwal's Health Care Ltd.
486.45
7.15 (1.49%)
Vijaya Diagnostic Centre Ltd.
1428.00
-9.70 (0.67%)
Natco Pharma Ltd.
821.30
-6.20 (0.75%)
Concord Biotech Ltd.
1374.10
0.50 (0.04%)
Molbio Diagnostics Ltd.
1513.10
204.20 (15.60%)
Rainbow Children's Medicare Ltd.
1279.80
-34.50 (2.62%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 325.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 28.26. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 4.59. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 43.03 & 3.62 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 14759.07 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 350.95 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MARKSANS
